Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

621 Real World Study

NCT: NCT05646004 · COMPLETED

NCT IDNCT05646004

StatusCOMPLETED

Start Date2023-01-09

Completion2023-11-27

SponsorCarl Zeiss Meditec AG (INDUSTRY)

First posted2022-12-12

Last updated2026-06-25

Brief Summary

This study is evaluating the clinical safety and effectiveness of 621, after cataract surgery.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑